Shencheng Ren
No. 180 Fenglin Road
Xuhui, China
Xuhui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma.
Journal: Cancer letters
Published: August 01, 2025
ZNF146 accelerates lung adenocarcinoma progression through MDM2/p53 and PHGDH/ferroptosis.
Journal: Cell & bioscience
Published: February 24, 2025
KLF13 promotes ferroptosis and chemosensitivity in lung adenocarcinoma.
Journal: BMC biology
Published: January 17, 2025
Transcription factor ZNF266 suppresses cancer progression by modulating CA9-mediated intracellular pH alteration in lung adenocarcinoma.
Journal: Respiratory research
Published: January 11, 2025
Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export.
Journal: Experimental hematology & oncology
Published: December 30, 2024
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC.
Journal: Nature communications
Published: November 04, 2024
Retinol-driven Gene Signatures Predict Lung Adenocarcinoma Outcomes and Highlight PAICS as a Therapeutic Opportunity.
Journal: Phenomics (Cham, Switzerland)
Published: June 05, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026